Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015674 (
chronic fatigue syndrome
)
2,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thirty-four patients with
chronic fatigue syndrome
(
CFS
) were compared with controls with
DSM
-III-R major depression on the Monospot and VP1 antigen tests. There was no significant difference in the numbers initially VP1 positive in the groups (11/34 and 7/34 positive in the chronic fatigue and major depression group respectively). Four
CFS
but no depressed patients were Monospot positive initially. No patient was both Monospot and VP1 positive. Patients positive on the tests were offered a repeat 6 months later. Eight of the 11 VP1 positive patients in the
CFS
group were retested and four remained positive, but none of the four depressed patients retested remained positive. No patient retested remained Monospot positive. The Monospot and VP1 tests appear to have little discriminating ability between these groups as screening tests and their predictive validity is unclear.
...
PMID:Monospot and VP1 tests in chronic fatigue syndrome and major depression. 143 20
We related reported physical symptoms, cognitive appraisals (e.g., negative style of thinking), and coping strategies (e.g., denial/disengagement strategies) with illness burden across several functional domains separately in subsets of
chronic fatigue syndrome
(
CFS
) patients with (n = 26) and without (n = 39) concurrently diagnosed major depressive disorder (MDD). In regard to cognitive appraisal measures, automatic thoughts and dysfunctional attitudes were strongly associated with a higher illness burden, as indicated in sickness impact profile (SIP) scores. Active-involvement coping strategies measured on COPE scales (active coping, planning, and positive reinterpretation and growth) were not associated with SIP scores, while other coping strategies (mental disengagement, behavioral disengagement, and denial) were positively correlated with psychosocial and physical SIP scales, especially those pertaining to interpersonal life-style arenas. After we accounted for the number of different
CFS
-specific physical complaints reported and
DSM
-III-R depression diagnosis status, cognitive appraisals and coping strategies predicted a substantial proportion of the variance in the severity of illness burden. For the most part, the magnitude of these relationships between our predictor model variables and illness burden severity was similar in the MDD and non-MDD subgroups.
...
PMID:Psychosocial correlates of illness burden in chronic fatigue syndrome. 814 57
This study was conducted to examine the rates of somatization disorder (SD) in the
chronic fatigue syndrome
(
CFS
) relative to other fatiguing illness groups. It further addressed the arbitrary nature of the judgments made in assigning psychiatric vs. physical etiology to symptoms in controversial illnesses such as
CFS
. Patients with
CFS
(N = 42), multiple sclerosis (MS) (N = 18), and depression (N = 21) were compared with healthy individuals (N = 32) on a structured psychiatric interview. The SD section of the Diagnostic Interview Schedule (DIS) III-R was reanalyzed using different criteria sets to diagnose SD. All subjects received a thorough medical history, physical examination, and DIS interview.
CFS
patients received diagnostic laboratory testing to rule out other causes of fatigue. This study revealed that changing the attribution of SD symptoms from psychiatric to physical dramatically affected the rates of diagnosing SD in the
CFS
group. Both the
CFS
and depressed subjects endorsed a higher percentage of SD symptoms than either the MS or healthy groups, but very few met the strict
DSM
-III-R criteria for SD. The present study illustrates that the terminology used to interpret the symptoms (ie, psychiatric or physical) will determine which category
CFS
falls into. The diagnosis of SD is of limited use in populations in which the etiology of the illness has not been established.
...
PMID:Assessing somatization disorder in the chronic fatigue syndrome. 867 89
The relationship of sleep complaints to mood, fatigue, disability, and lifestyle was examined in 69
chronic fatigue syndrome
(
CFS
) patients without psychiatric disorder, 58
CFS
patients with psychiatric disorder, 38 psychiatric out-patients with chronic depressive disorders, and 45 healthy controls. The groups were matched for age and gender. There were few differences between the prevalence or nature of sleep complaints of
CFS
patients with or without current
DSM
-IIIR depression, anxiety or somatization disorder.
CFS
patients reported significantly more naps and waking by pain, a similar prevalence of difficulties in maintaining sleep, and significantly less difficulty getting off to sleep compared to depressed patients. Sleep continuity complaints preceded fatigue in only 20% of
CFS
patients, but there was a strong association between relapse and sleep disturbance. Certain types of sleep disorder were associated with increased disability or fatigue in
CFS
patients. Disrupted sleep appears to complicate the course of
CFS
. For the most part, sleep complaints are either attributable to the lifestyle of
CFS
patients or seem inherent to the underlying condition of
CFS
. They are generally unrelated to depression or anxiety in
CFS
.
...
PMID:The relation of sleep difficulties to fatigue, mood and disability in chronic fatigue syndrome. 922 7
Tertiary care patients with chronic fatigue were followed for 2.5 years to determine if changes in physical and psychological status were associated with improvements in chronic fatigue, physical functioning, and return to work. Results indicated that improvement in psychological symptoms,
DSM
-III-R disorders, physical examination signs, and changes in whether the patient continued to meet criteria for
chronic fatigue syndrome
(
CFS
) were associated with recovery from fatigue, improved functioning, and return to work. Patients who never met
CFS
criteria or only met criteria at the initial assessment, reported improved physical functioning. Patients whose psychiatric disorders and physical examination signs were still present at a mean follow-up time of 2.5 years were more likely to have persistent fatigue and work disability. Loss of physical examination signs was a significant independent predictor of improved functioning and return to work. These results suggest that psychiatric status, as well as physical status, are associated with recovery from chronic fatigue.
...
PMID:Longitudinal changes associated with improvement in chronic fatigue patients. 972 Aug 56
Physicians require a screening instrument to detect psychiatric disorders in patients with
chronic fatigue syndrome
(
CFS
). Different threshold scores on the Hospital Anxiety and Depression scale (HAD) and the mental health scale of the Medical Outcome Survey (MOS) were compared with two gold standards for the presence or absence of psychiatric disorder, standard diagnostic criteria (
DSM
-III-R) and a threshold score for the number of psychiatric symptoms at a standardized psychiatric interview (Revised Clinical Interview Schedule total cut-off score of 11/12). They were compared by use of validating coefficients and receiver operating characteristics in 136 consecutive
CFS
medical outpatients. The HAD scale at cut-off of 9/10 was a valid and efficient screening instrument for anxiety and depression by comparison with both gold standards. The MOS mental health scale at its recommended cut-off score of 67/68 yielded too many false-positives to be recommended as a psychiatric screening instrument in
CFS
patients.
...
PMID:Screening instruments for psychiatric morbidity in chronic fatigue syndrome. 977 95
Chronic fatigue syndrome
(
CFS
) has been widely studied by neuroimaging techniques in recent years with conflicting results. In particular, using single-photon emission computed tomography (SPECT) and perfusion tracers, hypoperfusion has been found in several brain regions, although the findings vary across research centers. The objective of this study was to investigate brain metabolism of patients affected by
CFS
, using [18F]fluorine-deoxyglucose (18FDG) positron emission tomography (PET). We performed 18FDG PET in 18 patients who fulfilled the criteria of the working case definition of
CFS
. Twelve of the 18 patients were females; the mean age was 34 +/- 15 years (range, 15-68) and the median time from
CFS
diagnosis was 16 months (range, 9-138). Psychiatric diseases and anxiety/neurosis were excluded in all
CFS
patients.
CFS
patients were compared with a group of 6 patients affected by depression (according to
DSM
IV-R) and 6 age-matched healthy controls. The
CFS
patients were not taking any medication at the time of PET, and depressed patients were drug-free for at least 1 week before the PET examination. The PET images examined 22 cortical and subcortical areas.
CFS
patients showed a significant hypometabolism in right mediofrontal cortex (P = 0.010) and brainstem (P = 0.013) in comparison with the healthy controls. Moreover, comparing patients affected by
CFS
and depression, the latter group showed a significant and severe hypometabolism of the medial and upper frontal regions bilaterally (P = 0.037-0.001), whereas the metabolism of brain stem was normal. Brain 18FDG PET showed specific metabolism abnormalities in patients with
CFS
in comparison with both healthy controls and depressed patients. The most relevant result of our study is the brain stem hypometabolism which, as reported in a perfusion SPECT study, seems to be a marker for the in vivo diagnosis of
CFS
.
...
PMID:Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. 979 Apr 83
Presence of MRI brain abnormalities in patients with
Chronic Fatigue Syndrome
(
CFS
) was determined and the profile of MRI abnormalities was compared between 39
CFS
patients, 18 with (
CFS
-Psych) and 21 without (
CFS
-No Psych) a
DSM
-III-R Axis I psychiatric diagnosis since illness onset, and 19 healthy, sedentary controls (HC). Two neuroradiologists, blind to group membership, separately read the MR films using a detailed protocol for rating and categorizing abnormal signal changes. When findings were incongruent, the two neuroradiologists met to try to reach consensus, otherwise a third neuroradiologist evaluated the MR images and served as a tie-breaker. The
CFS
-No Psych group showed a significantly larger number of brain abnormalities on T2 weighted images than the
CFS
-Psych and HC groups. Cerebral changes in the
CFS
-No Psych group consisted mostly of small, punctate, subcortical white matter hyperintensities, found predominantly in the frontal lobes. No significant difference was found when both
CFS
groups were combined and compared to the HC group. The use of stratification techniques is an important strategy in understanding the pathophysiology of
CFS
. This frontal lobe pathology could explain the more severe cognitive impairment previously reported in this subset of
CFS
patients.
...
PMID:Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. 1056 41
The purpose of this study was to determine whether Gulf War Illness (GWI) can be explained by the presence of psychiatric disorders as assessed by
DSM
-III-R. To reduce the heterogeneity amongst Persian Gulf War veterans with GWI (PGV-F), only those were studied who presented with severe fatigue as a major complaint and also fulfilled clinical case definitions for
Chronic Fatigue Syndrome
, Idiopathic Chronic Fatigue, and/or Multiple Chemical Sensitivity. A total of 95 Registry PGVs were examined; 53 presented with GWI and 42 did not report any post-war health problems (PGV-H). All subjects were assessed for the presence of
DSM
-III-R Axis I psychiatric disorders. Compared to PGV-Hs, 49% of PGV-Fs had similar post-war psychiatric profiles: either no, or only one, psychiatric disorder was diagnosed. Psychiatric profiles of the remaining 51% of PGV-Fs were significantly different from PGV-Hs in that most of these veterans suffered from multiple post-war psychiatric diagnoses. The presence of psychiatric disorders as assessed by
DSM
-III-R criteria cannot explain symptoms of Gulf War Illness among all Persian Gulf veterans with severe fatiguing illness.
...
PMID:Psychiatric diagnoses in Gulf War veterans with fatiguing illness. 1064 76
PURPOSE: This study presents psychiatric correlates in
Chronic Fatigue Syndrome
(
CFS
) that emerged from the CDC's Surveillance Study. It seeks to determine the time of onset and rates of syndromal psychiatric disorders and identify the predominant disorder. Other goals are to ascertain whether depression is associated with
CFS
symptomatology, compare syndromal to self- reported depression, and test for the specificity of the 1988 CDC case definition for
CFS
.METHODS: All 565 enrolled subjects had fatiguing illnesses and were evaluated for
CFS
. They completed the Diagnostic Interview Schedule for the
DSM
-III-R and the Beck Depression Inventory. Prevalence estimates for current syndromal psychiatric disorders were calculated.
CFS
symptoms were compared by depression status. Syndromal and self-reported depression were contrasted. Groups that did and did not meet the case definition were compared by three outcome variables.RESULTS: Rates of current psychiatric disorders were high in CDC subjects compared to the community. The predominant disorder was depression. Although prior disorders tended to persist (75%), many disorders were incident to the fatiguing illness (57%). Depression was not associated with increased
CFS
symptomatology. There was only weak agreement between measures of syndromal and self-reported depression (kappa = 0.3219). Subjects designated as
CFS
had similar rates of syndromal psychiatric disorders, syndromal depression, and self-reported depression as did non-
CFS
subjects.CONCLUSIONS: Current syndrome; psychiatric disorders appear associated with fatiguing illnesses. While prior psychiatric disorders are risk factors for current, the onset was largely concurrent with the fatiguing illnesses. The BDI should probably not be used as a measure for psychiatric morbidity in
CFS
subjects. Regardless of outcome, there was no evidence of specificity of psychiatric features to the CDC case definition.
...
PMID:Psychiatric correlates in chronic fatigue syndrome. 1101 67
1
2
Next >>